Recovery and purification of biosynthetic products: Downstream processing for the 21st century
Conference - London, United Kingdom
The main challenges of the biopharmaceutical industry now are to increase the efficiency and reduce the costs of the manufacturing process, with respect to the protein recovery, purity and efficacy. Therefore, new strategies are being implemented for the upstream and downstream processing. In the upstream, genetic engineering and glycoengineering approaches, as well as single-use bioreactors are being developed and applied. However, as culture yields are continuously increasing, the bottleneck in the manufacturing process has shifted to the dowstream processing, which accounts for ~ 80% of the total production cost. Many aspects are being considered for improving economics in downstream processing, such as simplification of the chromatographic purification processes, application of membrane technology, crystallization and precipitation.
This meeting will focus on the advances, innovation and challenges in the area of downstream processing of biopharmaceuticals.
Organization: Euroscicon
(Courtesy of Biopharmaceuticals, via cleanroom.net)
Recovery and purification of biosynthetic products: Downstream processing for the 21st century
Wed, Nov 27, 2013 - Wed, Nov 27, 2013 (09:00 to 17:00 (GMT+00:00) UTC)
Cineworld: The O2 Peninsula Square, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
